This suggests the existence of a loop between the functions of APP metabolic products and PKC role, and that the dysregulated APP metabolism of several conditions, including AD, could have consequences on the potential protective functions of the non-amyloidogenic secreted APPα [99]. Here, PRRT2 is linked to Alzheimer disease.